ABIN183405
antibody from antibodies-online
Targeting: ARX
CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN183405 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-ARX (Middle Region) antibody
- Antibody type
- Polyclonal
- Antigen
- The immunogen for anti-ARX antibody: synthetic peptide directed towards the middle region of mouse ARX
- Description
- Protein A purified
- Reactivity
- Human, Mouse, Rat, Canine
- Host
- Rabbit
- Antigen sequence
TGAEDDEEELLEDEEDEEEEEELLEDDDEELLEDD
ARALL KEPRRCSVAT- Epitope
- Middle Region
- Vial size
- 100 μg
- Concentration
- 1mg/mL
- Storage
- -20°C
- Handling
- Avoid repeated freeze-thaw cycles.
Submitted references Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma.
Zinc-finger genes Fez and Fez-like function in the establishment of diencephalon subdivisions.
Zinc-finger gene Fez in the olfactory sensory neurons regulates development of the olfactory bulb non-cell-autonomously.
Condomines M, Hose D, Rème T, Requirand G, Hundemer M, Schoenhals M, Goldschmidt H, Klein B
Journal of immunology (Baltimore, Md. : 1950) 2009 Jul 15;183(2):832-40
Journal of immunology (Baltimore, Md. : 1950) 2009 Jul 15;183(2):832-40
Zinc-finger genes Fez and Fez-like function in the establishment of diencephalon subdivisions.
Hirata T, Nakazawa M, Muraoka O, Nakayama R, Suda Y, Hibi M
Development (Cambridge, England) 2006 Oct;133(20):3993-4004
Development (Cambridge, England) 2006 Oct;133(20):3993-4004
Zinc-finger gene Fez in the olfactory sensory neurons regulates development of the olfactory bulb non-cell-autonomously.
Hirata T, Nakazawa M, Yoshihara S, Miyachi H, Kitamura K, Yoshihara Y, Hibi M
Development (Cambridge, England) 2006 Apr;133(8):1433-43
Development (Cambridge, England) 2006 Apr;133(8):1433-43
No comments: Submit comment
No validations: Submit validation data